Download App
PAPER TRADE
Download App
Login
Feedback
CIPLA
newsbot
Reputation: 200,298 •
Oct 10, 2022 3:53 PM
Back-to-back US FDA approvals boost Zydus Lifesciences; stock at 8-month high
The US accounts for 40 percent of the company’s revenue, which is why each FDA approval is a positive
Moneycontrol
https://www.moneycontrol.com/news/business/stocks/back-to...
#CIPLA
#SUNPHARMA
#ZYDUSLIFE
Vote
Comment
Share
NSE:CIPLA price when posted: 1,116.2